Skip to main content

Axsome Therapeutics, Inc.

AXSM
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001579428

In the last 90 days, Axsome Therapeutics, Inc. insiders filed 0 open-market purchases and 3 sales; 505 institutions reported holding it in 13F filings for Q2 2026, worth $9.34B in total; no superinvestor holds it.

Members of Congress who traded AXSM

Since 2020, newest trade first. Options and trades reported under an earlier ticker are included.

Trades
1
Filings
1
Members
1
Buys / sells
1 / 0
Estimated volume
$32.5K
Sum of range midpoints
Members of Congress who traded AXSM
MemberTradesBuys / sellsEst. volumeLast tradedLast filed
Chris JacobsRepublican · House · NY11 / 0$32.5KJun 16, 2022Jul 28, 2022

Trades

Every reported trade in Axsome Therapeutics, Inc., newest filings first.

Congress trades
MemberAssetTypeOwnerTradedFiledDelayAmountSource
Chris JacobsRepublican · House · NYAXSMAxsome Therapeutics, Inc.BuySelfJun 16, 2022Jul 28, 202242 days$15K-$50KFiling

Source: U.S. House Clerk and Senate Office of Public Records (eFD). Amounts are the ranges filers report.